GLYC Price Targets and Analyst Ratings NASDAQ:GLYC
GLYC Forecast. What You Should Know.
GLYC Historical Ratings and Targets
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.